Vident Investment Advisory’s NovoCure NVCR Stock Holding History

Vident Investment Advisory’s Portfolio NVCR Stock Details NVCR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell
2023 Q1	$398K	Buy
2022 Q4	$345K	Buy
2022 Q3	$270K	Buy
2022 Q1	–	Sell
2021 Q4	$341K	Buy
2021 Q3	$314K	Buy
2021 Q2	$348K	Sell
2021 Q1	$316K	Sell
2020 Q4	$440K	Buy